<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00273000</url>
  </required_header>
  <id_info>
    <org_study_id>GLP-2, MBF</org_study_id>
    <nct_id>NCT00273000</nct_id>
  </id_info>
  <brief_title>The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans</brief_title>
  <official_title>The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the effect of GLP-2 on mesenteric bloodflow in healthy
      adults by the use of ultrasound., it is the hypothesis that GLP-2 vil increase the bloodflow.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigation will include 10 testpersons.

      It will be a 2 fase study over 2 days.

      day 1: The testperson will meet fasting, and take in a standard liquid meal, after this the
      bloodflow in a mesenteric artery will be measured by use of ultrasonic technique.
      Bloodsamples will be taken regular in a total wolumne of 200 ml.

      day 2:The testperson will meet fasting, there wil be administered intraveneous GLP-2 in 3
      increasing doses over 3 x 45 min.and one subcutaneous dose. During this the bloodflow in a
      mesenteric artery will be measured by use of ultrasonic technique. Bloodsamples will be taken
      regular in a total wolumne of 200 ml.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2006</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment>10</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GLP-2</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy

        Exclusion Criteria:

          -  use of drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mads Hornum, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup University Hospital, Copenhagen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lasse Bremholm Hansen, MD</last_name>
    <phone>004560927874</phone>
    <email>hoersted-bremholm@webspeed.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen City</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lasse Bremholm Hansen, MD</last_name>
      <phone>004560927874</phone>
      <email>hoersted-bremholm@webspeed.dk</email>
    </contact>
    <investigator>
      <last_name>Mads Hornum, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2006</study_first_submitted>
  <study_first_submitted_qc>January 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2006</study_first_posted>
  <last_update_submitted>September 7, 2006</last_update_submitted>
  <last_update_submitted_qc>September 7, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2006</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucagon</mesh_term>
    <mesh_term>Glucagon-Like Peptide 1</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

